Regeneron Pharmaceuticals, Inc.

NASDAQ:REGN   3:59:56 PM EDT
611.71
-3.53 (-0.57%)
4:26:37 PM EDT: $612.98 +1.27 (+0.21%)
Other Pre-Announcement

Regeneron Pharmaceuticals - Sees Prelim U.S. Net Product Sales Of Regen-Cov Of About $5.82 Bln For FY 2021

Published: 01/10/2022 11:41 GMT
Regeneron Pharmaceuticals, Inc. (REGN) - Regeneron Pharmaceuticals - Sees Prelim U.S. Net Product Sales of Regen-cov of About $5.82 Billion for Full Year 2021.
Regeneron Pharmaceuticals - Sees Prelim U.S. Net Product Sales of Eylea Injection of About $5.79 Billion for Full Year 2021.
Regeneron Pharmaceuticals - FDA No Longer Plans to Convene an Advisory Committee to Discuss Regen-cov Bla for Treatment and Prophylaxis.